Pathologie is a distinguished academic journal published by Springer Heidelberg, dedicated to advancing the field of pathology and forensic medicine. With an ISSN of 2731-7188 and an E-ISSN of 2731-7196, this journal serves as a vital platform for researchers, professionals, and students to disseminate innovative findings and insights. Currently ranked in the Q3 category of pathology and forensic medicine according to the 2023 metrics, Pathologie reflects a commitment to quality and relevance in a dynamic research landscape. Despite its relatively recent establishment from 2022, the journal is gaining traction with a Scopus rank of 139 out of 208 in its category, positioning itself as an emerging resource within the academic community. While it operates under a subscription model, the importance of the journal lies in its objective to facilitate the exploration of diverse pathological processes and enhance forensic methodologies, ultimately improving clinical outcomes and investigative practices. As it continues to grow, Pathologie stands poised to impact the pathology domain significantly.

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

Virchows Archiv, published by Springer, is an esteemed journal dedicated to the fields of Medicine and Pathology, featuring high-quality research from various domains including Cell Biology and Molecular Biology. With its inception dating back to 1947, Virchows Archiv has been a pivotal platform for advancing the understanding of pathological and forensic medicine. As evidenced by its impressive Scopus rank, placing it within the top 15% of journals in Pathology and Forensic Medicine, it continues to maintain a strong presence with a Q1 classification in its category as of 2023. Although it does not offer Open Access options, the journal remains critical for researchers and professionals seeking to publish and access pioneering findings that can impact clinical practices and the academic community. The journal’s rigorous peer-review process ensures that only the highest quality research is disseminated, making it an essential resource for those engaged in the ever-evolving fields of health and biological sciences.

Annual Review of Cancer Biology is a pivotal journal published by Annual Reviews, specializing in the rapidly evolving field of cancer research. With an impact factor positioned in the distinguished Q1 quartile of Cancer Research, Cell Biology, and Oncology categories, this journal ensures that it showcases the highest quality of scholarly contributions. Indexed in Scopus, it ranks among the top in its fields, reflecting its strong influence and relevance, with remarkable percentiles indicating its esteemed position within the research community. Although not an open-access journal, it provides a comprehensive platform for advancing the frontiers of cancer biology through rigorously curated reviews, highlighting key developments, breakthroughs, and future directions that inform both academia and clinical applications. As a valuable resource for researchers, professionals, and students, the Annual Review of Cancer Biology serves as an essential guide for understanding and addressing the complexities of cancer biology today.

JCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.

ADVANCES IN ANATOMIC PATHOLOGY is a leading peer-reviewed journal dedicated to the field of anatomical pathology, published by LIPPINCOTT WILLIAMS & WILKINS. With an impressive impact factor and consistent ranking in the Q1 category for both Anatomy and Pathology and Forensic Medicine, it serves as an essential resource for researchers, clinicians, and students alike. The journal has been a critical platform for disseminating significant findings and advancements in the discipline since its inception in 1996, boasting Scopus rankings of #1 in Anatomy and #11 in Pathology. While it does not provide open access, it maintains rigorous standards in the selection of articles, ensuring that published research reflects the latest developments and techniques in the field. As we look toward 2024 and beyond, ADVANCES IN ANATOMIC PATHOLOGY remains committed to advancing the science of pathology, fostering innovation, and enhancing clinical practice through impactful research.

PATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.

npj Breast Cancer, published by NATURE PORTFOLIO, stands at the forefront of breast cancer research as an esteemed open access journal since 2015. With its impressive trajectory, the journal has garnered a notable impact within the academic community, reflecting a Q1 ranking in prestigious categories such as Oncology, Pharmacology, and Radiology for 2023. Based in the United Kingdom and indexed under E-ISSN 2374-4677, npj Breast Cancer aims to disseminate cutting-edge research that fosters innovation in prevention, diagnosis, and treatment of breast cancer, thereby addressing one of the most pressing health issues of our time. Its placement within Scopus rankings, including a remarkable 19th position in Pharmacology and a percentile ranking in the 90th range for Radiology and Oncology, highlights its significance as a key resource for researchers, healthcare professionals, and policy-makers dedicated to advancing cancer care. Emphasizing accessibility and high-quality content, npj Breast Cancer provides an influential platform for interdisciplinary collaboration and discovery in the ongoing battle against breast cancer.

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

Cancer Genetics is an esteemed peer-reviewed journal dedicated to advancing the field of cancer research through the lens of genetics. Published by Elsevier Science Inc and available in both print (ISSN: 2210-7762) and online (E-ISSN: 2210-7770), this journal aims to provide a platform for the dissemination of high-quality studies that unravel the genetic underpinnings of cancer. Since its inception in 2011, Cancer Genetics has become a significant resource for researchers, professionals, and students with a shared interest in understanding the intricate relationship between genetics and oncogenesis. With an impact factor that reflects its influence, the journal has maintained a Q3 ranking in Cancer Research, Genetics, and Molecular Biology as of 2023, indicating its growing importance in these fields. Additionally, the journal offers open access options to ensure that crucial findings are easily accessible to the global research community. By bridging the gap between genetics and cancer studies, Cancer Genetics plays a pivotal role in fostering innovation and collaboration among scientists and clinicians striving to improve cancer diagnosis and treatment.